Elevated urinary excretion of nitric oxide metabolites in young infants with Zellweger syndrome

Clinica Chimica Acta

Volumn 334, Issue 1-2, 2003, Pages 111-115

  Surdacki, Andrzej ^a,c   Tsikas, Dimitrios ^a   Mayatepek, Ertan ^b   Frölich, Jürgen C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

GC MS; Nitric oxide; Urinary nitrate; Zellweger syndrome

Indexed keywords

ARACHIDONIC ACID; ARGININE; NITRATE; NITRIC OXIDE;

AGE DISTRIBUTION; ARTICLE; BIOSYNTHESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; CREATININE URINE LEVEL; DISEASE MARKER; GAS CHROMATOGRAPHY; HUMAN; INFANCY; INFANT; MASS SPECTROMETRY; METABOLITE; PEROXISOME; PRIORITY JOURNAL; URINARY EXCRETION; ZELLWEGER SYNDROME;

EID: 12444292074     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00230-4     Document Type: Article

References (25)

1. 2α in urine of healthy humans and patients with Zellweger syndrome by gas chromatography-tandem mass spectrometry. J. Chromatogr. B. 716:1998;7-17.
2. Mayatepek E., Lehmann W.D., Fauler J., Tsikas D., Frölich J.C., Schutgens R.B.et al. Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders. J. Clin. Invest. 91:1993;881-888.
3. Fauler J., Tsikas D., Mayatepek E., Keppler D., Frölich J.C. Impaired degradation of prostaglandins and thromboxane in Zellweger syndrome. Pediatr. Res. 36:1994;449-455.
4. 2α in rat pulmonary artery. Br. J. Pharmacol. 120:1997;1280-1285.
5. 2α, in experimental hypercholesterolemia. Cardiovasc. Res. 44:1999;601-607.
6. Larfars G., Lantoine F., Devynck M.A., Palmblad J., Gyllenhammar H. Activation of nitric oxide release and oxidative metabolism by leukotrienes B4, C4, and D4 in human polymorphonuclear leukocytes. Blood. 93:1999;1399-1405.
7. Walch L., Norel X., Gascard J.P., Brink C. Functional studies of leukotriene receptors in vascular tissues. Am. J. Respir. Crit. Care Med. 16:2000;S107-S111.
8. Shimokawa H., Flavahan N.A., Lorenz R.R., Vanhoutte P.M. Prostacyclin releases endothelium-derived relaxing factor and potentiates its action in coronary arteries of the pig. Br. J. Pharmacol. 95:1988;1197-1203.
9. Honold J., Pusser N.L., Nathan L., Chaudhuri G., Ignarro L.J., Sherman M.P. Production and excretion of nitrate by human newborn infants: neonates are not little adults. Nitric Oxide. 4:2000;35-46.
10. Tsukahara H., Hiraoka M., Hori C., Tsuchida S., Hata I., Nishida K.et al. Urinary nitrite/nitrate excretion in infancy: comparison between term and preterm infants. Early Hum. Dev. 47:1997;51-56.
11. Tsukahara H., Hiraoka M., Hori C., Miyanomae T., Kikuchi K., Sudo M. Age-related changes of urinary nitrite/nitrate excretion in normal children. Nephron. 76:1997;307-309.
12. Dollberg S., Warner B.W., Myatt L. Urinary nitrite and nitrate concentrations in patients with idiopathic persistent pulmonary hypertension of the newborn and effect of extracorporeal membrane oxygenation. Pediatr. Res. 37:1995;31-34.
13. Trachtman H., Gauthier B., Frank R., Futterweit S., Goldstein A., Tomczak J. Increased urinary nitrite excretion in children with minimal change nephrotic syndrome. J. Pediatr. 128:1996;173-176.
14. Uzuner N., Islekel H., Ozkan H., Sen A., Yenice S., Cevik N. Urinary nitrite excretion in low birth weight neonates with systemic inflammatory response syndrome. Biol. Neonate. 71:1997;362-366.
15. van Straaten E.A., Koster-Kamphuis L., Bovee-Oudenhoven I.M., van der Meer R., Forget P.P. Increased urinary nitric oxide oxidation products in children with active coeliac disease. Acta Paediatr. 88:1999;528-531.
16. Goonasekera C.D.A., Shah V., Rees D.D., Dillon M.J. Nitric oxide activity in childhood hypertension. Arch. Dis. Child. 77:1997;11-16.
17. Koeck T., Kremser K. Peroxisomal deficiences are associated with altered activity of endothelial NOS in human fibroblasts. Nitric Oxide. 5:2001;213-218.
18. Lazarow P.B., Moser H.W. Disorders of peroxisome biogenesis. Scriver C.R., Beaudet C.L., Sly W.S., Valle D. The metabolic and molecular bases of inherited disease. 1995;2287-2324 McGraw-Hill, New York.
19. Tsikas D., Gutzki F.M., Rossa S., Bauer H., Neumann C., Dockendorff K.et al. Measurement of nitrite and nitrate in biological fluids by gas chromatography-mass spectrometry and by the Griess assay: problems with the Griess assay-solutions by gas chromatography-mass spectrometry. Anal. Biochem. 244:1997;208-220.
20. Gryglewski R.J., Palmer R.M., Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 320:1986;454-456.
21. Keller G.A., Warner T.G., Steimer K.S., Hallewell R.A. Cu,Zn superoxide dismutase is a peroxisomal enzyme in human fibroblasts and hepatoma cells. Proc. Natl. Acad. Sci. U. S. A. 88:1991;7381-7385.
22. Spisni E., Cavazzoni M., Griffoni C., Calzolari E., Tomasi V. Evidence that photodynamic stress kills Zellweger fibroblasts by a nonapoptotic mechanism. Biochim. Biophys. Acta. 1402:1998;61-69.
23. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am. J. Physiol. 271:1996;C1424-C1437.
24. Kremser K., Stangl H., Pahan K., Singh I. Nitric oxide regulates peroxisomal enzyme activities. Eur. J. Clin. Chem. Clin. Biochem. 33:1995;763-764.
25. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch. Biochem. Biophys. 356:1998;1-11.